A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 27,300 shares of CDMO stock, worth $335,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,300
Previous 21,300 28.17%
Holding current value
$335,790
Previous $152,000 103.95%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.7 - $12.45 $763,257 - $1.42 Million
113,919 Added 10.75%
1,173,489 $13.4 Million
Q2 2024

Aug 14, 2024

SELL
$6.34 - $9.28 $3.9 Million - $5.71 Million
-615,524 Reduced 36.75%
1,059,570 $7.57 Million
Q1 2024

May 15, 2024

BUY
$5.86 - $8.79 $8.15 Million - $12.2 Million
1,390,252 Added 488.08%
1,675,094 $11.2 Million
Q4 2023

Feb 14, 2024

SELL
$4.64 - $9.56 $3.5 Million - $7.21 Million
-754,479 Reduced 72.59%
284,842 $1.85 Million
Q3 2023

Nov 14, 2023

BUY
$9.4 - $14.04 $8.71 Million - $13 Million
926,903 Added 824.51%
1,039,321 $9.81 Million
Q2 2023

Aug 14, 2023

BUY
$12.96 - $20.93 $921,909 - $1.49 Million
71,135 Added 172.31%
112,418 $1.57 Million
Q1 2023

May 15, 2023

SELL
$13.48 - $18.79 $49,849 - $69,485
-3,698 Reduced 8.22%
41,283 $774,000
Q4 2022

Feb 14, 2023

BUY
$12.61 - $18.74 $308,465 - $458,417
24,462 Added 119.22%
44,981 $619,000
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $314,556 - $417,766
20,519 New
20,519 $392,000
Q1 2022

May 16, 2022

BUY
$16.63 - $27.73 $1.12 Million - $1.87 Million
67,556 Added 581.68%
79,170 $1.61 Million
Q4 2021

Feb 14, 2022

SELL
$20.7 - $34.18 $2.2 Million - $3.62 Million
-106,056 Reduced 90.13%
11,614 $338,000
Q3 2021

Nov 15, 2021

BUY
$19.05 - $28.32 $1.09 Million - $1.62 Million
57,033 Added 94.06%
117,670 $2.54 Million
Q2 2021

Aug 16, 2021

SELL
$18.93 - $25.65 $1.45 Million - $1.97 Million
-76,849 Reduced 55.9%
60,637 $1.56 Million
Q1 2021

May 17, 2021

SELL
$11.86 - $21.77 $527,781 - $968,786
-44,501 Reduced 24.45%
137,486 $2.51 Million
Q4 2020

Feb 16, 2021

BUY
$7.25 - $11.76 $96,374 - $156,325
13,293 Added 7.88%
181,987 $2.1 Million
Q3 2020

Nov 16, 2020

BUY
$6.53 - $8.6 $949,344 - $1.25 Million
145,382 Added 623.64%
168,694 $1.29 Million
Q2 2020

Aug 14, 2020

BUY
$4.11 - $6.78 $32,711 - $53,962
7,959 Added 51.84%
23,312 $153,000
Q1 2020

May 15, 2020

SELL
$3.15 - $7.39 $119,564 - $280,502
-37,957 Reduced 71.2%
15,353 $78,000
Q4 2019

Feb 14, 2020

SELL
$5.01 - $8.16 $210,264 - $342,467
-41,969 Reduced 44.05%
53,310 $409,000
Q2 2019

Aug 14, 2019

BUY
$3.43 - $5.6 $78,324 - $127,875
22,835 Added 31.52%
95,279 $533,000
Q4 2018

Feb 14, 2019

SELL
$4.04 - $6.75 $67,476 - $112,738
-16,702 Reduced 18.74%
72,444 $297,000
Q3 2018

Nov 13, 2018

BUY
$4.28 - $7.32 $50,944 - $87,129
11,903 Added 15.41%
89,146 $0
Q2 2018

Aug 10, 2018

BUY
$3.1 - $3.93 $37,252 - $47,226
12,017 Added 18.42%
77,243 $0
Q1 2018

May 11, 2018

BUY
$2.32 - $4.22 $151,324 - $275,253
65,226 New
65,226 $190,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $765M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.